MTOR and gastric cancer: A recent study found that the dual PI3K/mTOR inhibitor BEZ235 reduced growth of NCI-N87 but not MKN45 and MKN28 gastric cancer xenografts, while tumor growth control did not correlate with PI3K/mTOR inhibition but thymidine kinase1 expression (25).